Extracorporeal Shock Wave Therapy Versus High Power LASER Therapy for the Treatment of Females With Calcaneal Spur

NCT ID: NCT06510673

Last Updated: 2024-08-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-01

Study Completion Date

2025-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

PURPOSE: To compare the effect of Extracorporeal shock wave therapy and high-power LASER therapy for the treatment of patients with calcaneal spur Background: Calcaneal spur is a common musculoskeletal disorder of the foot that affect the quality-of-life Conservative treatment modalities include, cold application, platelet-rich plasma therapy (PRP), shoe modification, therapeutic ultrasound, extracorporeal shock wave therapy (ESWT), laser therapy (LLLT) are commonly used in the treatment of calcaneal spur.

HYPOTHESES: There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on pain intensity in patients with calcaneal spur There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on function in patients with calcaneal spur. There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on the size of calcaneal spur in patients with calcaneal spur.

RESEARCH QUESTION: Is there any difference between the effect of Extracorporeal shock wave therapy and High-power LASER on calcaneal spur?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Calcaneal Spur

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Shockwave therapy

Shockwave therapy for calcaneal spur

Group Type EXPERIMENTAL

Shockwave therapy

Intervention Type OTHER

Shockwave therapy sessions for the heel

High-power LASER therapy

High-power LASER therapy for calcaneal spur

Group Type EXPERIMENTAL

High power LASER

Intervention Type OTHER

High power LASER sessions for the heel

Control

cold application with receive 6 sessions of sham LASER therapy.

Group Type SHAM_COMPARATOR

Ice application

Intervention Type OTHER

Ice application for the heel

Sham LASER

Intervention Type OTHER

Sham LASER for the heel

Platelet rich plasma

Platelet-rich plasma injection for the heel

Group Type EXPERIMENTAL

Platelet rich plasma

Intervention Type DRUG

Platelet-rich plasma for the heel

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Platelet rich plasma

Platelet-rich plasma for the heel

Intervention Type DRUG

High power LASER

High power LASER sessions for the heel

Intervention Type OTHER

Shockwave therapy

Shockwave therapy sessions for the heel

Intervention Type OTHER

Ice application

Ice application for the heel

Intervention Type OTHER

Sham LASER

Sham LASER for the heel

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

diagnosed with calcaneal spur based on clinical examination and radiological findings.

Exclusion Criteria

were as follows: acute trauma to the foot, history of fracture or surgery, lower extremity neurological deficit, polyneuropathy, radicular pain, autoimmune diseases tumor, thrombosis, soft tissue or bone infection, or skin disorder.
Minimum Eligible Age

25 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Suez University

OTHER

Sponsor Role collaborator

Badr University

OTHER

Sponsor Role collaborator

Helwan University

OTHER

Sponsor Role collaborator

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mina Magdy Wahba

Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Doaa Elsayed

Role: STUDY_CHAIR

Department of Physical therapy for Woman's Health, Faculty of Physical Therapy, Badr University in Cairo, Cairo, Egypt

Doha Hamed

Role: STUDY_CHAIR

Basic Sciences Department, Faculty of Physical Therapy, Badr University in Cairo

Ahmed Zakaria

Role: STUDY_CHAIR

Department of orthopedic surgery, Helwan University

Omnya Samy

Role: STUDY_DIRECTOR

Department of Physical Therapy for Pediatrics and Pediatric Surgery, Faculty of Physical Therapy, Badr University in Cairo

Fatma Zidan

Role: STUDY_DIRECTOR

Department of Physical therapy for Neuromuscular Disorders & its Surgery, Faculty of Physical Therapy, Badr University in Cairo

Doaa Saeed

Role: STUDY_CHAIR

Department of Physical Therapy for Women's Health, Faculty of Physical Therapy, Badr University in Cairo, Cairo, Egypt

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Badr University in Cairo (BUC)

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mina Wahba, PhD

Role: CONTACT

01285170876

Doha Hamed, PhD

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SU1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

HeEL Pain Pathways Feasibility Study
NCT06967168 RECRUITING NA
INIT Versus IASTM In Patients With Chronic PF
NCT06493487 NOT_YET_RECRUITING NA